novo nordisk semaglutide products and competitors faces 'must-win' battle over U.S. Wegovy, Ozempic in 2026 Novo Nordisk to protect US

Cash pay also provides flexibility in dosing and treatment protocols

House Minority Caucus Chair Lindsey Burke, D-Lexington, believes HB 732 would create a huge gray area. I would go as far as to argue that this bill incentivizes employers to misclassify their workers, undermining job quality for Kentuckians, she said, adding it could leave self-employed workers underpaid and at-risk

At first, she was intimidated by the class

Fischer AJ, Stanke JJ, Ghai K, Scott M, Omar G

However, practical factors such as cost, patient adherence, and tolerability often make an add-on approach more feasible in real-world settings

Community: Peer support to counter the isolation that quietly derails progress